2.6301
前日終値:
$2.61
開ける:
$2.59
24時間の取引高:
848.80K
Relative Volume:
1.85
時価総額:
$203.03M
収益:
-
当期純損益:
-
株価収益率:
2.3678
EPS:
1.1108
ネットキャッシュフロー:
-
1週間 パフォーマンス:
+17.21%
1か月 パフォーマンス:
+24.43%
6か月 パフォーマンス:
-82.02%
1年 パフォーマンス:
-82.02%
Accendra Health Inc Stock (ACH) Company Profile
Compare ACH vs MCK, COR, CAH, HSIC, AHG
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
ACH
Accendra Health Inc
|
2.625 | 201.87M | 0 | 0 | 0 | 0.00 |
|
MCK
Mckesson Corporation
|
948.86 | 116.05B | 397.96B | 4.55B | 9.64B | 34.77 |
|
COR
Cencora Inc
|
366.42 | 70.24B | 325.78B | 1.64B | 3.61B | 8.3139 |
|
CAH
Cardinal Health Inc
|
225.87 | 52.81B | 244.67B | 1.68B | 5.51B | 6.9487 |
|
HSIC
Henry Schein Inc
|
80.54 | 9.37B | 12.50B | 314.00M | 421.00M | 2.44 |
|
AHG
Akso Health Group Adr
|
1.36 | 1.16B | 2.22M | -5.63M | -1.68M | -0.24 |
Accendra Health Inc Stock (ACH) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-11-03 | ダウングレード | UBS | Buy → Neutral |
| 2024-07-19 | アップグレード | Citigroup | Neutral → Buy |
| 2024-02-26 | 開始されました | Leerink Partners | Market Perform |
| 2024-01-03 | 開始されました | Barclays | Equal Weight |
| 2022-10-13 | ダウングレード | Citigroup | Buy → Neutral |
| 2022-10-12 | ダウングレード | BofA Securities | Buy → Underperform |
| 2022-10-12 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2022-04-26 | 再開されました | Citigroup | Buy |
| 2022-04-01 | 再開されました | Credit Suisse | Neutral |
| 2022-03-30 | 再開されました | JP Morgan | Underweight |
| 2022-03-23 | アップグレード | HSBC Securities | Reduce → Hold |
| 2021-04-08 | アップグレード | JP Morgan | Neutral → Overweight |
| 2021-03-08 | アップグレード | Goldman | Sell → Buy |
| 2020-12-17 | アップグレード | UBS | Neutral → Buy |
| 2020-09-25 | アップグレード | Barclays | Underweight → Equal Weight |
| 2020-07-21 | アップグレード | BofA Securities | Neutral → Buy |
| 2020-07-21 | アップグレード | Robert W. Baird | Neutral → Outperform |
| 2020-07-14 | アップグレード | Credit Suisse | Neutral → Outperform |
| 2020-05-05 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2020-04-23 | 再開されました | Credit Suisse | Neutral |
| 2020-01-21 | アップグレード | Robert W. Baird | Neutral → Outperform |
| 2020-01-07 | ダウングレード | Goldman | Neutral → Sell |
| 2019-11-15 | アップグレード | CLSA | Underperform → Outperform |
| 2019-09-06 | 繰り返されました | BofA/Merrill | Neutral |
| 2019-04-10 | 繰り返されました | BofA/Merrill | Neutral |
| 2019-04-03 | アップグレード | BofA/Merrill | Neutral → Buy |
| 2019-04-01 | アップグレード | JP Morgan | Underweight → Overweight |
| 2019-01-18 | アップグレード | HSBC Securities | Hold → Buy |
| 2019-01-17 | 開始されました | UBS | Neutral |
| 2019-01-15 | アップグレード | CLSA | Underperform → Outperform |
| 2018-12-14 | ダウングレード | Morgan Stanley | Overweight → Underweight |
| 2018-12-12 | ダウングレード | Goldman | Buy → Neutral |
| 2018-09-28 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2018-04-11 | ダウングレード | CLSA | Outperform → Sell |
| 2018-04-10 | アップグレード | Credit Suisse | Neutral → Outperform |
| 2018-03-26 | アップグレード | Goldman | Sell → Neutral |
| 2017-11-02 | ダウングレード | HSBC Securities | Buy → Hold |
| 2016-03-24 | アップグレード | Goldman | Sell → Neutral |
| 2015-12-07 | ダウングレード | Goldman | Neutral → Sell |
| 2015-08-31 | アップグレード | Credit Suisse | Underperform → Neutral |
| 2012-08-01 | 開始されました | HSBC Securities | Underweight |
| 2009-08-05 | アップグレード | Citigroup | Sell → Buy |
| 2008-12-01 | ダウングレード | HSBC Securities | Neutral → Underweight |
すべてを表示
Accendra Health Inc (ACH) 最新ニュース
UBS cuts Accendra Health stock price target on 2026 guidance By Investing.com - Investing.com India
UBS cuts Accendra Health stock price target on 2026 guidance - Investing.com Australia
Tighter CMS Coverage Rules Put Accendra Health’s Non-Invasive Ventilation Revenue and Liquidity at Risk - TipRanks
Accendra Health: Debt Reduction Creates Long-Term Opportunity (Upgrade) (NYSE:ACH) - Seeking Alpha
Accendra Health (ACH) Faces Lowered Price Target by Leerink Part - GuruFocus
Accendra Health bets on Optum contract, leaner structure - HME News
Accendra Health : Reports Fourth Quarter 2025 Financial Results Prepared Remarks - marketscreener.com
Accendra Health sees 3% YOY growth, embarks on ‘next chapter’ - HME News
Accendra Health earnings missed by $0.01, revenue fell short of estimates - Investing.com Nigeria
Accendra Health Inc (ACH) Q4 2025 Earnings Call Highlights: Navi - GuruFocus
Accendra Health reports Q4 adjusted EPS 21c, consensus 22c - TipRanks
Accendra Health Posts 2025 Results, Guides 2026 Outlook - TipRanks
Accendra Health Reports Fourth Quarter 2025 Financial Results - marketscreener.com
Earnings Scheduled For February 19, 2026 - Benzinga
Accendra Health Announces Fourth Quarter 2025 Earnings Release Date and Conference Call - Business Wire
MSN Money - MSN
Accendra Health Stock Surges on Key Executive Appointment - AD HOC NEWS
Owens & Minor Appoints Dirk Benson as Chief Commercial Officer, Effective February 4, 2026 - marketscreener.com
Accendra Health Begins Trading Under 'ACH' Ticker After Owens & Minor Divestment - marketscreener.com
Owens & Minor, Inc. (OMI) Stock Analysis: Exploring a 94% Potential Upside in Healthcare Distribution - DirectorsTalk Interviews
Owens & Minor changes name to Accendra Health - MSN
Owens & Minor, Inc. (OMI): Investor Outlook Reveals 94% Potential Upside Amidst Challenging Valuation - DirectorsTalk Interviews
AASTOCKS Financial NewsAccendra Health, Inc. (ACH) - AASTOCKS.com
Owens & Minor rebrands as Accendra Health in transformation - MSN
Accendra Health (ACH) Price Target Decreased by 69.55% to 3.77 - Nasdaq
Accendra Health (ACH): Citigroup Lowers Price Target, Maintains Buy Rating | ACH Stock News - GuruFocus
Implied Volatility Surging for Accendra Health Stock Options - sharewise.com
ACH (Accendra Health) Interest Coverage : 1.94 (As of Sep. 2025) - GuruFocus
ACH (Accendra Health) Current Deferred Revenue : $0 Mil (As of Sep. 2025) - GuruFocus
ACH (Accendra Health) ROCE % : 6.66% (As of Sep. 2025) - GuruFocus
Return on assets % of Accendra Health, Inc. – NYSE:ACH - TradingView — Track All Markets
Accendra Health, Inc. Revenue Breakdown – NYSE:ACH - TradingView — Track All Markets
Total debt per share of Accendra Health, Inc. – NYSE:ACH - TradingView — Track All Markets
ETFs Investing in Accendra Health, Inc. Stocks - TradingView — Track All Markets
ACH Forecast — Price Target — Prediction for 2027 - TradingView
Gree Says Won’t Hike Air-Con Prices, Swap Copper for Aluminum Despite Metal’s Surging Cost - Yicai Global
Accendra Health, Inc. Bonds — Corporate Bond Rates - TradingView — Track All Markets
Total revenue of Accendra Health, Inc. – BOATS:ACH - TradingView — Track All Markets
Accendra Health (NYSE: OMI) adds pro forma data on P&HS sale - Stock Titan
China Metals & Mining Industry Report 2025, Profiles of Jiangxi Copper, China Shenhua Energy Co, Zijin Mining Group, Aluminum Corp of China - Yahoo Finance
It’s official: Accendra Health goes live on NYSE, unveils new website - HME News
"Post-70s" Lu Dongliang became Vice Governor of Shanxi Province before becoming Chairman of Aluminum Corporation of China - Shanghai Metals Market
Owens & Minor Completes Sale of Products & Healthcare Services Business to Platinum Equity - citybiz
ACH Seasonals Chart - TradingView — Track All Markets
Revenue per share of Accendra Health Inc – SWB:6OM - TradingView — Track All Markets
Accendra Health, Inc. Financial Disclosures & SEC Filings - TradingView — Track All Markets
Free cash flow per share of Accendra Health Inc – SWB:6OM - TradingView — Track All Markets
Chalco’s Stock Tests Investor Nerves As Aluminum Cycle Turns: Is The Worst Finally Priced In? - AD HOC NEWS
Alcoa Corp Is Popping Off: Is AA Stock a Sleepy Boomer Metal Play or a Sneaky Viral Win? - AD HOC NEWS
Accendra Health, Inc.: Dividend historical data and projections - MarketScreener
Accendra Health, Inc.: Target Price Consensus and Analysts Recommendations | 6OM | US6907321029 - MarketScreener
Accendra Health Inc (ACH) 財務データ
Accendra Health Inc (ACH) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
Accendra Health Inc (ACH) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Coliseum Capital Management, L | 10% Owner |
Aug 14 '25 |
Buy |
5.31 |
492,852 |
2,617,044 |
13,100,807 |
| Coliseum Capital Management, L | 10% Owner |
Aug 13 '25 |
Buy |
5.46 |
325,000 |
1,774,500 |
12,607,955 |
| Coliseum Capital Management, L | 10% Owner |
Apr 09 '25 |
Buy |
7.39 |
225,000 |
1,662,750 |
11,482,955 |
| Coliseum Capital Management, L | 10% Owner |
Apr 08 '25 |
Buy |
7.96 |
105,000 |
835,800 |
11,257,955 |
| Coliseum Capital Management, L | 10% Owner |
Apr 10 '25 |
Buy |
7.19 |
80,000 |
575,200 |
11,562,955 |
| Coliseum Capital Management, L | 10% Owner |
Apr 07 '25 |
Buy |
7.84 |
240,000 |
1,881,600 |
11,152,955 |
| Coliseum Capital Management, L | 10% Owner |
Apr 03 '25 |
Buy |
8.53 |
160,000 |
1,364,800 |
10,784,599 |
| Coliseum Capital Management, L | 10% Owner |
Apr 04 '25 |
Buy |
8.14 |
128,356 |
1,044,818 |
10,912,955 |
| Coliseum Capital Management, L | 10% Owner |
Feb 28 '25 |
Buy |
9.39 |
1,738,511 |
16,324,618 |
9,469,698 |
| Coliseum Capital Management, L | 10% Owner |
Mar 04 '25 |
Buy |
9.75 |
800,000 |
7,800,000 |
10,624,599 |
大文字化:
|
ボリューム (24 時間):